Parallax Volatility Advisers
GH icon

Parallax Volatility Advisers’s Guardant Health GH Stock Holding History

Parallax Volatility Advisers’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.7M Buy
185,000
+15,000
+9% +$1.51M 0.04% 285
2025
Q4 		$17.4M Sell
170,000
-1,230,000
-88% -$110M 0.03% 337
2025
Q3 		$87.5M Buy
1,400,000
+160,000
+13% +$8.7M 0.13% 83
2025
Q2 		$64.5M Buy
1,240,000
+5,000
+0.4% +$223K 0.15% 103
2025
Q1 		$52.6M Buy
1,235,000
+62,000
+5% +$2.67M 0.14% 118
2024
Q4 		$35.8M Buy
1,173,000
+10,600
+0.9% +$298K 0.07% 217
2024
Q3 		$26.7M Buy
1,162,400
+354,800
+44% +$10M 0.05% 266
2024
Q2 		$23.3M Buy
807,600
+298,400
+59% +$6.95M 0.05% 271
2024
Q1 		$10.5M Buy
+509,200
New +$10.9M 0.02% 497
2022
Q4 		– Sell
-294,900
Closed -$15.9M – 3025
2022
Q3 		$15.9M Buy
+294,900
New +$15.1M 0.02% 592

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parallax Volatility Advisers's GH Position: Q1 2025 in Review

Parallax Volatility Advisers sold out of Guardant Health (GH) in Q1 2025, closing a stake of 40 shares — an estimated $1.73K sold.

Parallax Volatility Advisers first reported a position in GH in Q4 2019 and held it in 4 quarters. The position peaked at $2.76M in Q3 2022. 342 funds tracked by Wall St. Rank hold GH as of Q1 2025.

  • Parallax Volatility Advisers reported no remaining Guardant Health position as of Q1 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 40 Guardant Health shares in Q1 2025, an estimated $1.73K.
  • Parallax Volatility Advisers first reported a position in Guardant Health in Q4 2019 and held it in 4 quarters.
  • Parallax Volatility Advisers's Guardant Health position peaked at $2.76M in Q3 2022.
  • 342 funds tracked by Wall St. Rank held Guardant Health as of Q1 2025.

Based on Parallax Volatility Advisers's 13F filing for Q1 2025, filed 15 May 2025.